KalVista (KALV) announced that Japan’s Ministry of Health, Labour and Welfare, or MHLW, has granted sebetralstat orphan drug designation. The company has also submitted a new drug application ...
GlobalData on MSN12d
Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacksCSL Behring KK has gained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) to manufacture and market subcutaneous (SC) injection 200mg Andembry pens designed to prevent acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback